Services
Company
Legal and Governance
Publication Library / Publications
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain
Aim
To describe treatment patterns and outcomes in nontransplant newly diagnosed multiple myeloma (NDMM) patients in Spain.
Methods
This retrospective study included two cohorts of NDMM patients diagnosed between 1 January 2012 to 31 December 2013 and 1 April 2016 to 31 March 2017.
Results
Among 113 patients, proteasome inhibitor (PI) + alkylator combinations (49%) and PI-based regimens without an alkylator (30%) were the most common first-line (1L) therapies. Use of PI + immunomodulatory drug-based regimens increased between the cohorts; PI-based regimens without an alkylator/immunomodulatory drug decreased. Use of 1L oral regimens was low but increased over time; use of maintenance therapy was low across both periods. Median 1L duration of treatment was 6.9 months.
Conclusion
Short 1L duration of treatment and low use of 1L oral regimens and maintenance therapy highlight unmet needs in NDMM.
Authors
J-Á Hernández-Rivas, M Arnao, J M A Pérez, A Rubio, E G García, D de Miguel, D Cherepanov, D Romanus, K Verleger, C Johnson, S L Corman, M Grande, E P Persona
Journal
Future Oncology
Therapeutic Area
Oncology
Center of Excellence
Real-world Evidence & Data Analytics
Year
2021
Read full article